Archives by
Month/Year
Best Practices & Innovative Tactics for Cost Containment
April 2011
Benefits & Pension Summit, Toronto
Breakthrough in Multiple Sclerosis (MS) treatment: the first oral MS drug approved for sale in Canada
April 2011
Gilenya™ (fingolimod) is the first oral MS drug approved for sale in Canada, representing a true breakthrough for patients with MS: whereas previous treatments were limited to injectable therapies, this new class of medications is available as a convenient once-a-day capsule... View post
Drug Plans Face Historic Squeeze
National Post (April 2011)
A growing tide of highpriced specialty medicines for arthritis, cancer and other diseases is set to put unprecedented pressure on workplace drug plans, likely forcing strict limits... Download PDF
How drug pricing changes will impact plan sponsors
Benefits Canada (April 2011)
The new generic drug pricing changes that have taken place across the country have created some evolving implications for plan sponsors. Download PDF
NOC Watch – Vimovo, Revolade
April 2011
Vimovo is a new brand name product that is indicated for the relief of pain and inflammation associated with several forms of arthritis...Revolade is an "orphan drug" approved for use in Canada for the treatment of Idiopathic (Immune) Thrombocytopenia Purpura (ITP), a rare blood disorder. View post
Latest News
-
N.S. tightens rules on OxyContin -Globe and Mail (February 20, 2012) - Provinces become proactive after being accused of inaction in the face of rising addiction rates - Nova Scotia has become the latest... View post
-
Another Blockbuster Falls: Generic Plavix® Now Available - February 2012 - After over 8 years of patent challenges between the Canadian generic manufacturing company Apotex and the product’s innovator, sanofi-aventis, clopidogrel (generic for... View post
-
Protecting Your Plan from the Gravy Train - February 2012 - Although full-product direct-to-consumer advertising (DTCA) is illegal in Canada, most Canadians are exposed to this type of advertising through media spillage from... View post
-
Many Canadians can’t afford to take drugs as directed -Globe and Mail (January 17, 2012) - One in four Canadians who do not have drug insurance are unable to afford to take their prescription drugs as directed, a... View post
-
Look ahead with predictive modelling -Benefits Canada (January 2012) - The most recent 24 months of data is one of the most important pieces of information that plan sponsors and advisors have... Download PDF
-
Drug Plans Erode Over Last 20 Years -Benefits and Pensions monitor (December 2011) - All of us involved in the provision and management of drug plan benefits should be embarassed by the lack of progress over... Download PDF
-
Are we in 2002 or 2012? A word of caution about mail-order pharmacies -Benefits Canada (November 2011) - If a plan design does not support mail order (or any other preferred pharmacy arrangement) in a meaningful way, it will be... Download PDF
Connect
